Fulgent Genetics FLGT
$24.12 −$0.66 (-2.66%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.12 0.00%
Open$24.50
Prev close$24.78
Day range$23.88 – $24.79
Volume323.0K
Market cap$673.89M
P/E (TTM)–
Dividend yield–
FLGT Stock News
Headlines matching Fulgent Genetics or the FLGT ticker, most recent first.
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 Negative
- Fulgent Genetics (FLGT.US) will release its earnings report after market close on July 30.
- Earnings Call Summary | Fulgent Genetics(FLGT.US) Q1 2026 Earnings Conference
- Fulgent Genetics (FLGT.US) will release its earnings report before the market opens on May 1.
- UBS Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Cuts Target Price to $22 Negative
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Maintains Target Price $19
- Fulgent Genetics (FLGT.US) will release its financial results after the market close on November 5.
- UBS Initiates Fulgent Genetics(FLGT.US) With Buy Rating, Announces Target Price $30
- Raymond James Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Maintains Target Price $25
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $21 Negative
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Raises Target Price to $23 Positive
- Raymond James Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Announces Target Price $25
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $16 Negative
- UBS Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $20 Negative
- Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Raises Target Price to $30 Positive
No comments yet — be the first to weigh in on FLGT.
Sign in to join the discussion.